Reported adverse events and pregnancy outcomes from four observational studies in pregnant women without contraindications to exercise
| Study, n | Total events reported during SupE | Events at rest (LLP) | Events during SupE | Pregnancy outcomes and adverse events listed by author |
| Green et al, 22 n=26 | 11 (42%) | Reduced variability for FHR tracing. | Reduced variability for FHR tracing. | Apgars 4:8; meconium staining; normal BW. |
| Non-reactive variability for FHR tracing. | Non-reactive FHR variability. | Apgars 0:0; stillbirth. | ||
| Bradycardia. | Normal FHR tracing. | Apgars 9:9; normal BW. | ||
| Variable decelerations for FHR tracing. | Reduced FHR reactivity and variability. | Caesarean section; SGA; Apgars 9:9. | ||
| Normal. | Variable FHR decelerations. | Apgars 7:9; normal BW. | ||
| Normal. | Reduced FHR reactivity and variability. | Apgars 6:6; normal BW. | ||
| Normal. | Reduced FHR reactivity and variability. | Caesarean section; 37 weeks; Apgars 9:9. | ||
| Normal. | Reduced FHR reactivity and variability. | Apgars 0:0; stillbirth. | ||
| Normal. | Reduced FHR reactivity and variability. | Apgars 8:9; normal BW. | ||
| Normal. | Reduced FHR reactivity and variability. | Apgars 9:10; normal BW. | ||
| Normal. | Reduced FHR reactivity and variability. | Apgars 9:9; normal BW. | ||
| Normal. | Reduced FHR reactivity and variability. | Apgars 9:9; normal BW. | ||
| Nesler et al, 19 n=27 | 5 (19%) | Non-reactive FHR tracing. | Did not engage in supine exercise (dropped). | Term; no complications. |
| Bradycardia. | Did not engage in supine exercise (dropped). | Term; no complications. | ||
| Variable FHR decelerations. | Variable FHR decelerations. | Term; no complications. | ||
| Variable FHR decelerations. | Variable FHR decelerations. | Term; no complications. | ||
| Variable FHR decelerations. | Variable FHR decelerations. | IUGR; decrease in amniotic fluid; <37 weeks; caesarean section. |